NCT04739813 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04737265 Pilot Study of an NTproBNP Guided Strategy of Cardioprotection Status COMPLETED Phase PHASE1/PHASE2
NCT04716153 Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer Status TERMINATED Phase NA
NCT04706676 Integrative Neuromuscular Training in Adolescents and Children Treated for Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04703985 Evaluation of the Success of Prophylactic Enteral Nutrition in Therapeutic Intensification With Autograft of Autologous Hematopoietic Cells in Hematology Status COMPLETED Phase N/A
NCT04701554 EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL Status COMPLETED Phase NA
NCT04668768 HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma Status SUSPENDED Phase PHASE2
NCT04657302 A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT04637763 CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) Status RECRUITING Phase PHASE1
NCT04610125 Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children Status UNKNOWN Phase NA
NCT04604158 Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients Status COMPLETED Phase NA
NCT04593277 Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study Status COMPLETED Phase NA
NCT04571138 A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04570423 A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy Status RECRUITING Phase PHASE2
NCT04556266 A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies Status WITHDRAWN Phase PHASE1
NCT04541212 Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04514029 Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1